Pulmonx Corporation

LUNG US7458481014

🆔
Registration No.
5432095
💰
Capitalization
Small-cap

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

🔗
Website
Annual Performance 1
2021 2022 2023 2024 2025
-46% -76% 70% -47% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
107
🙍
Insiders
8
Person Price Shares Total Published Completed
Williamson Steven S.
CEO 		1.60
USD 		4,530
Sold 		7,248
USD 		02/09/2025 02/09/2025
Joshi Mehul
CFO 		1.60
USD 		4,271
Sold 		6,834
USD 		02/09/2025 02/09/2025
Lehman David Aaron
SR OFF 		1.60
USD 		929
Sold 		1,486
USD 		02/09/2025 02/09/2025
Lehman David Aaron
SR OFF 		1.60
USD 		2,068
Sold 		3,309
USD 		02/09/2025 02/09/2025
Rose Geoffrey Beran
CCO 		1.60
USD 		1,575
Sold 		2,520
USD 		02/09/2025 02/09/2025
Lehman David Aaron
SR OFF 		1.60
USD 		3,231
Sold 		5,170
USD 		02/09/2025 02/09/2025
Rose Geoffrey Beran
CCO 		1.60
USD 		1,799
Sold 		2,878
USD 		02/09/2025 02/09/2025
Rose Geoffrey Beran
CCO 		1.60
USD 		707
Sold 		1,131
USD 		02/09/2025 02/09/2025
Lehman David Aaron
SR OFF 		1.60
USD 		3,541
Sold 		5,666
USD 		02/09/2025 02/09/2025
Williamson Steven S.
CEO 		1.60
USD 		5,118
Sold 		8,189
USD 		02/09/2025 02/09/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Pulmonx Corporation to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
7% -7% -30% -49% 0% 0% -83%
Last 52W Low 52W High All-Time Low All-Time High β
1.73 1.51 7.37 1.51 7.37
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
French Glendon E. Iii 16 1,613,844.32 100,865.27 01/12/2023 20/03/2025
Lehman David Aaron 33 407,561.16 12,350.34 01/12/2023 02/09/2025
Williamson Steven S. 6 341,631.05 56,938.51 20/08/2024 02/09/2025
Rose Geoffrey Beran 36 299,242.71 8,312.30 23/10/2023 02/09/2025
Joshi Mehul 7 165,573.54 23,653.36 03/03/2025 02/09/2025
Florin Daniel P 2 142,724.52 71,362.26 05/06/2025 05/06/2025
Ferrari Richard 1 25,280.00 25,280.00 12/06/2025 12/06/2025
Mckune John 6 19,505.61 3,250.93 01/12/2023 01/03/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.